Back to Driehaus Capital Management LLC Driehaus Capital Management LLC

SKYE

Showing 6 of 7 quarters

Position history for Driehaus Capital Management LLCDriehaus Capital Management LLC's holdings in Skye Bioscience, Inc.

No. Driehaus Capital Management exited its SKYE (Skye Bioscience) position in Q4 2025. Its Q3 2025 13F listed 620,395 shares worth $2.4M. Driehaus Capital Management already held SKYE in its Q2 2024 13F, the earliest on record, and held it in 6 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$2.5M

Total Shares Change

-650,758

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$6.00
0
2025-Q3
Unchanged
620,395
0.0%
$2.4M0.0%$31.44
0
2025-Q2
Unchanged
620,395
0.0%
$2.6M0.0%$33.44
0
2025-Q1
Decreased
620,395
-4.7%
$986,4280.0%$12.72
0
2024-Q4
Unchanged
650,758
0.0%
$1.8M0.0%$22.64
0
2024-Q3
Unchanged
650,758
0.0%
$2.5M0.0%$31.28
0

Other major holders of SKYE: BlackRock Finance, Inc., Janus Henderson Group Ltd., Baker Bros. Advisors LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used